Circadian Rhythms of Carbohydrate Metabolism in Women with Different Types of Obesity

Bulletin of Experimental Biology and Medicine

Volumn 161, Issue 3, 2016, Pages 323-326

  Pinkhasov, B B ^a   Selyatinskaya, V G ^a   Astrakhantseva, E L ^a   Anufrienko, E V ^a  

^a Research Institute of Experimental and Clinical Medicine   (Russian Federation)

Author keywords

circadian rhythm; glucose tolerance test; gynoid and android obesity types; insulin; women

Indexed keywords

CARBOHYDRATE; IMMUNOREACTIVE INSULIN; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ANDROID OBESITY; ARTICLE; CARBOHYDRATE METABOLISM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; GYNOID OBESITY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; TIME FACTOR; ADOLESCENT; METABOLISM; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CIRCADIAN RHYTHM; FEMALE; HUMANS; INSULIN; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 84983000195     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-016-3406-2     Document Type: Article

References (12)

1. Pinchasov BB, Astrakhantseva EL, Shorin YP, Kogay MA, Selyatitskaya VG. Individual reactivity features of female organism with different type of obesity on nutrition deprivation. Sib. Nauch. Med. Zh. 2009; 29(3):115-121. Russian.
2. Selyatitskaya VG, Pinkhasov BB, Karapetyan AR, Kuzminova OI. Adipokines and a risk for metabolic disturbances in different types of female obesity. Ter. Arkhiv. 2015; (10):80-84. Russian.
3. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003; 52(1):102-10.
4. Van Cauter E., Blackman J.D., Roland D., Spire J.P., Refetoff S., Polonsky K.S. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 1991; 88(3): 934-942. doi: 10.1172/JCI115396.
5. Froy O. The circadian clock and metabolism. Clin Sci (Lond). 2011; 120(2):65-72. doi: 10.1042/CS20100327.
6. Gonnissen HK, Hulshof T, Westerterp-Plantenga MS. Chronobiology, endocrinology, and energy- and food-reward homeostasis. Obes Rev. 2013; 14(5):405-16. doi: 10.1111/obr.12019.
7. Pinkhasov BB, Selyatitskaya VG, Karapetyan AR, Astrakhantseva EL. Metabolic syndrome in men and women with upper or lower types of body fat distribution. Health. 2012; 4(12A):1381-1389.
8. Prasai MJ, George JT, Scott EM. Molecular clocks, type 2 diabetes and cardiovascular disease. Diab Vasc Dis Res. 2008; 5(2):89-95. doi: 10.3132/dvdr.2008.015.
9. Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab (Seoul). 2014 29; 29(4):427-34. doi: 10.3803/EnM.2014.29.4.427.
10. Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol. 2011; 57(3):249-56. doi: 10.1016/j.jjcc.2011.02.006.
11. Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci. 2006; 331(4):166-74.
12. Young ME, Bray MS. Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Med. 2007; 8(6): 656-667.